Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ImpediMed Limited
  6. Summary
    IPD   AU000000IPD8

IMPEDIMED LIMITED

(IPD)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
07/22/2021 07/23/2021 07/26/2021 07/27/2021 07/28/2021 Date
0.099 0.105 0.105 0.096 0.097 Last
2892969 2399850 1390101 6094137 1169388 Volume
-1.00% +6.06% 0.00% -8.57% +1.04% Change
Estimated financial data (e)
Sales 2021 8,60 M 6,34 M 6,34 M
Net income 2021 -20,7 M -15,2 M -15,2 M
Net cash position 2021 19,2 M 14,2 M 14,2 M
P/E ratio 2021 -5,89x
Yield 2021 -
Sales 2022 18,7 M 13,8 M 13,8 M
Net income 2022 -15,2 M -11,2 M -11,2 M
Net cash position 2022 20,1 M 14,8 M 14,8 M
P/E ratio 2022 -9,44x
Yield 2022 -
Capitalization 145 M 106 M 107 M
EV / Sales 2021 14,6x
EV / Sales 2022 6,67x
Nbr of Employees 69
Free-Float 89,6%
More Financials
Company
ImpediMed Limited is an Australia-based company, which is a global provider of medical technology to measure, monitor and manage fluid status and body composition. The principal activities of the Company consist of the development, manufacture and sale of bioimpedance instruments and consumables, and the sale of electronic test and measurement devices. The Company's operating segments include Medical, and Test &... 
More about the company
Ratings of ImpediMed Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about IMPEDIMED LIMITED
06/07Impedimed Announces Next Generation of Sozo« Digital Health Platform Software
CI
05/24ImpediMed Limited Announces Official Release of SOZO Version 4.0 Software
CI
04/22IMPEDIMED : Receives FDA Clearance for SOZO Device's Heart Failure Index
MT
04/21ImpediMed Limited Announces FDA Clearance for SOZO Heart Failure Index
CI
04/07IMPEDIMED : Sozo Clinical Utility Study Published in Peer-Reviewed Medical Journ..
MT
04/07ImpediMed Limited Announces SOZO Clinical Utility in Heart Failure Published
CI
03/03IMPEDIMED : Completes 200,000 Patient Tests on Digital Health Platform SOZO; Sha..
MT
02/22IMPEDIMED : Narrows Net Loss in July-December 2020
MT
02/21ImpediMed Limited Reports Earnings Results for the Half Year Ended December 3..
CI
02/11IMPEDIMED : American College of Cardiology Accepts Impedimed's Heart Failure Tec..
MT
01/11IMPEDIMED : Closes PREVENT Trial upon Completion of Final Patient Follow-up
MT
01/10ImpediMed Limited Announces PREVENT Trial Finishes ş- Final Patient Completes..
CI
2020Impedimed Limited Announces the Publication of A Meta-Analysis, Demonstrating..
CI
2020Aussie Shares on Three-Day Winning Streak; Australia Posts Subdued Wage Growt..
MT
2020IMPEDIMED : Shares Jump 10% After Securing First Commercial Sales for Heart Fail..
MT
More news
News in other languages on IMPEDIMED LIMITED

- No features available -

More news
Chart IMPEDIMED LIMITED
Duration : Period :
ImpediMed Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMPEDIMED LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 0,10 AUD
Average target price 0,22 AUD
Spread / Average Target 127%
EPS Revisions
Managers and Directors
Richard Carreon Chief Executive officer, MD & Executive Director
Timothy Cruickshank Chief Financial Officer & Executive Vice President
Scott R. Ward Non-Executive Chairman
Frank Vicini Chief Medical Officer
Shashi Tripathi Chief Technology Officer
Sector and Competitors